# Regadenoson

NDC: 43598-616
Generic name: Regadenoson
Labeler / Manufacturer: Dr. Reddy's Laboratories Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20230423

FDA application: ANDA213210

## Active ingredients

- REGADENOSON ANHYDROUS: .08 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"43598-616"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=43598-616
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=03ef6420-8190-a404-f7f6-def1864a77de